Skip to main content
. 2023 May 19;5(1):vdad056. doi: 10.1093/noajnl/vdad056

Table 3.

Determinants of fatigue as measured with the MFI-20 summary score

Determinant OR (95% CI)
Sex 0.9 (0.5−1.7), P = 0.732
Age 1.0 (0.97−1.02), P = 0.576
Educational level
Low (reference)
Intermediate 0.9 (0.5−1.7), P = 0.716
High 0.3 (0.20.7), P = 0.005
Number of comorbidities 1.6 (1.31.9), P < 0.001
Tumor location
Multiple locations (reference)
Cerebral convexity 1.2 (0.4−3.1), P = 0.738
Skull base 0.6 (0.2−1.6), P = 0.331
Falx 1.0 (0.3−3.0), P = 0.988
Other 1.0 (0.3−3.5), P = 0.939
Tumor size
No tumor (complete resection) (reference)
<40 mm 1.2 (0.6−2.3), P = 0.581
≥40 mm 0.9 (0.2−4.8), P = 0.867
WHO grade
1 (reference)
2 2.2 (1.05.2), P = 0.064
Unknown/not clear 0.4 (0.13.7), P = 0.453
Seizures in the past 3 months 1.1 (0.91.5), P = 0.285
Underwent resection 1.7 (0.55.9), P = 0.373
Underwent radiotherapy 2.4 (1.24.8), P = 0.019
Complications after resection 3.6 (1.87.0), P < 0.001

OR, odds ratio, CI, confidence interval.

Statistically significant differences are outlined in bold.